One of my most significant professional achievements has been leading a small team to execute key experiments that supported a recent IND submission to the FDA, an experience I found both rewarding and impactful.

The highly supportive, friendly, and collaborative environment, which made the experience both enjoyable and accessible, particularly as an international student.

Read more. It’s easy to focus narrowly on a specific research field during graduate school, but there is an incredible breadth of exciting work beyond your immediate area. The knowledge gained from exploring diverse publications will prove valuable over time.

PMY taught me how to think like a scientist. Learning how to formulate hypotheses, rigorously test them, and communicate findings clearly has been invaluable throughout my career. Those skills have had a lasting impact on how I approach both research and leadership.

I have always been passionate about science and research, and working in a science-driven organization where discoveries translate into real-world therapies has been especially inspiring.

I would love to teach a class on the current boom in antibody–drug conjugates (ADCs) for cancer treatment. This field has undergone a remarkable transformation over the past few years, with exciting breakthroughs across multiple cancer types that have significantly expanded the therapeutic potential of ADCs. The combination of targeted antibody delivery and highly potent payloads has made ADCs one of the most dynamic and promising areas in oncology today.

For required reading, I would recommend “Exploring the Next Generation of Antibody–Drug Conjugates” by Kyoji Tsuchikama and colleagues. It provides an excellent overview of the field and highlights many of the innovations that are driving the next wave of ADC development.